DK2222272T3 - Behandling af luftvejssygdom - Google Patents

Behandling af luftvejssygdom

Info

Publication number
DK2222272T3
DK2222272T3 DK09784868.3T DK09784868T DK2222272T3 DK 2222272 T3 DK2222272 T3 DK 2222272T3 DK 09784868 T DK09784868 T DK 09784868T DK 2222272 T3 DK2222272 T3 DK 2222272T3
Authority
DK
Denmark
Prior art keywords
treatment
respiratory disease
respiratory
disease
Prior art date
Application number
DK09784868.3T
Other languages
English (en)
Inventor
Harry Finch
Craig Fox
Mohammed Sajad
Original Assignee
Pulmagen Therapeutics Inflammation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0814488A external-priority patent/GB0814488D0/en
Priority claimed from GB0823568A external-priority patent/GB0823568D0/en
Application filed by Pulmagen Therapeutics Inflammation Ltd filed Critical Pulmagen Therapeutics Inflammation Ltd
Application granted granted Critical
Publication of DK2222272T3 publication Critical patent/DK2222272T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK09784868.3T 2008-08-07 2009-08-05 Behandling af luftvejssygdom DK2222272T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0814488A GB0814488D0 (en) 2008-08-07 2008-08-07 Respiratory disease treatment
GB0823568A GB0823568D0 (en) 2008-12-24 2008-12-24 Respiratory disease treatment
PCT/GB2009/001920 WO2010015818A1 (en) 2008-08-07 2009-08-05 Respiratory disease treatment

Publications (1)

Publication Number Publication Date
DK2222272T3 true DK2222272T3 (da) 2013-02-11

Family

ID=41202662

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09784868.3T DK2222272T3 (da) 2008-08-07 2009-08-05 Behandling af luftvejssygdom

Country Status (21)

Country Link
EP (1) EP2222272B1 (da)
JP (1) JP5689797B2 (da)
CN (1) CN102170864B (da)
AU (1) AU2009279077C1 (da)
BR (1) BRPI0917567A2 (da)
CA (1) CA2733440C (da)
CY (1) CY1113744T1 (da)
DK (1) DK2222272T3 (da)
EA (1) EA019339B1 (da)
ES (1) ES2399179T3 (da)
GB (1) GB2465897B (da)
HR (1) HRP20130052T1 (da)
IL (1) IL210959A0 (da)
MX (1) MX2011001418A (da)
NZ (1) NZ590774A (da)
PL (1) PL2222272T3 (da)
PT (1) PT2222272E (da)
SI (1) SI2222272T1 (da)
SM (1) SMT201300007B (da)
WO (1) WO2010015818A1 (da)
ZA (1) ZA201100750B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007079078A1 (en) 2005-12-29 2007-07-12 Bayer Schering Pharma Aktiengesellschaft Diamine derivatives as inhibitors of leukotriene a4 hydrolase
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
GB0913672D0 (en) 2009-08-05 2009-09-16 Argenta Discovery Ltd Glitazones
RU2564661C2 (ru) 2009-12-15 2015-10-10 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ
GB2477540A (en) * 2010-02-05 2011-08-10 Argenta Therapeutics Ltd Respiratory disease treatment
WO2011098746A1 (en) * 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB2477743A (en) * 2010-02-10 2011-08-17 Argenta Therapeutics Ltd Enantiomers of 5-methyl-thiazolidine-2,4-dione glitazone compounds
GB201002224D0 (en) * 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002243D0 (en) * 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
ES2864862T3 (es) 2013-03-12 2021-10-14 Celltaxis Llc Métodos de inhibición de la leucotrieno A4 hidrolasa
CA2941562C (en) 2013-03-14 2021-09-21 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
MX2015011677A (es) 2013-03-14 2016-07-08 Celtaxsys Inc Inhibidores de leucotrieno a4 hidrolasa.
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
US9402884B2 (en) * 2014-09-08 2016-08-02 Barry Burns Methods of treating pulmonary sarcoidosis
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
DK3439667T3 (da) 2016-04-05 2024-04-02 Immune Sensor Llc Cgas antagonist forbindelser
KR101841589B1 (ko) * 2016-12-02 2018-03-23 주식회사 종근당 로베글리타존을 유효성분으로 포함하는 섬유증 예방 또는 치료용 약학적 조성물
US11931345B2 (en) 2018-05-04 2024-03-19 Cirius Therapeutics, Inc. Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseases
EP3801559B1 (en) 2018-05-31 2025-01-01 Celltaxis, LLC Method of reducing pulmonary exacerbations in respiratory disease patients
AU2020218272A1 (en) 2019-02-08 2021-09-02 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
WO2021011874A1 (en) 2019-07-18 2021-01-21 University Of Miami Ghrh antagonists for use in a method of treating sarcoidosis
US20210315937A1 (en) * 2020-04-08 2021-10-14 University Of South Florida Methods of treating inflammation
WO2021212054A1 (en) * 2020-04-17 2021-10-21 Cirius Therapeutics, Inc. Methods and compositions for treating subjects with metabolic disorders and coronavirus infections
EP4142720A1 (en) * 2020-04-30 2023-03-08 Minoryx Therapeutics S.L. Leriglitazone for treating lung inflammation and interstitial lung disease
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
JP2023553290A (ja) * 2020-12-01 2023-12-21 リバースパ エルエルシー 慢性閉塞性肺疾患、喘息、肺炎、気管支炎、嚢胞性線維症、肺水腫、間質性肺疾患、サルコイドーシス、特発性肺胞線維症、急性呼吸窮迫症候群、および肺動脈性肺高血圧症を治療するための方法および組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2335597A (en) * 1998-03-27 1999-09-29 Glaxo Group Ltd Stereoisomers of Troglitazone in the Treatment of Diabetes
US6127394A (en) * 1999-03-08 2000-10-03 The University Of Mississippi 1,2-Dithiolane derivatives
GB9908647D0 (en) * 1999-04-15 1999-06-09 Smithkline Beecham Plc Novel compounds
AU2001288271A1 (en) * 2000-08-17 2002-02-25 Harrihar A. Pershadsingh Methods for treating inflammatory diseases
AU2002343094A1 (en) * 2001-11-26 2003-06-10 Arachnova Therapeutics Ltd. Use of ppar activators for the treatment of pulmonary fibrosis
US7981915B2 (en) * 2003-04-30 2011-07-19 Beth Israel Deaconess Medical Center Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene
TWI297606B (en) * 2004-01-16 2008-06-11 Nat Health Research Institutes Cancer therapy
WO2007100027A1 (ja) * 2006-03-02 2007-09-07 Daiichi Sankyo Company, Limited 光学活性なチアゾリジンジオン誘導体

Also Published As

Publication number Publication date
HK1156501A1 (en) 2012-06-15
GB201000468D0 (en) 2010-02-24
JP5689797B2 (ja) 2015-03-25
EA201100305A1 (ru) 2011-10-31
JP2011529953A (ja) 2011-12-15
MX2011001418A (es) 2011-07-20
EA019339B1 (ru) 2014-02-28
CY1113744T1 (el) 2016-06-22
ZA201100750B (en) 2012-06-27
PL2222272T3 (pl) 2013-04-30
ES2399179T3 (es) 2013-03-26
WO2010015818A1 (en) 2010-02-11
GB2465897B (en) 2011-02-09
CN102170864B (zh) 2015-04-01
CA2733440C (en) 2016-06-28
CA2733440A1 (en) 2010-02-11
NZ590774A (en) 2012-09-28
AU2009279077A1 (en) 2010-02-11
GB2465897A (en) 2010-06-09
IL210959A0 (en) 2011-04-28
EP2222272B1 (en) 2012-11-07
CN102170864A (zh) 2011-08-31
BRPI0917567A2 (pt) 2015-11-17
AU2009279077C1 (en) 2014-12-04
PT2222272E (pt) 2013-01-29
AU2009279077B2 (en) 2014-07-03
HRP20130052T1 (hr) 2013-02-28
EP2222272A1 (en) 2010-09-01
SMT201300007B (it) 2013-03-08
SI2222272T1 (sl) 2013-03-29

Similar Documents

Publication Publication Date Title
DK2222272T3 (da) Behandling af luftvejssygdom
DK2488242T3 (da) Medicinsk indåndingsmaske
EP2296593A4 (en) MEDICAL HEAD COVER
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
BRPI1011813A2 (pt) "inalador"
BRPI0906366A2 (pt) Inalador
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
BRPI0914817A2 (pt) inalador
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
DK2373927T3 (da) Behandling af forbrændingsgas fra affaldsbehandling
DK2252317T3 (da) Behandling af makuladegeneration
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
PL2435825T3 (pl) Sposoby leczenia chorób
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
BRPI0906779A2 (pt) Inalador
DK2056858T3 (da) Behandling af lungesygdomstilstande
DK2173831T3 (da) Brøndbehandling
FI20085693A0 (fi) Biosignaalin prosessointi
EP3381471C0 (en) PAIN TREATMENT
BRPI0906367A2 (pt) inalador
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
SMT201600156B (it) Trattamento dell’osteoartrite